Pfizer Inc (PFE)

49.19
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    43.88 - 43.88
Trading near 52-week Low

Pfizer has hit the lowest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

PFE Overview

Prev. Close
49.19
Day's Range
43.88-43.88
Revenue
76.04B
Open
43.88
52 wk Range
43.88-55.19
EPS
5.31
Volume
0
Market Cap
248.22B
Dividend (Yield)
1.64
(3.33%)
Average Volume (3m)
21
P/E Ratio
8.24
Beta
0.651
1-Year Change
-11.05%
Shares Outstanding
5,613,314,537
Next Earnings Date
01 May 2023
What is your sentiment on Pfizer?
or
Vote to see community's results!

Pfizer Inc News

Pfizer Inc Analysis

Pfizer Inc Company Profile

Pfizer Inc Company Profile

Employees
79000
  • Type:Equity
  • Market:Chile
  • ISIN:US7170811035

Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. Its Vaccines include Comirnaty/BNT162b2, the Prevnar family, Nimenrix and others. Its Oncology products include Ibrance, Xtandi, Inlyta, Sutent, Retacrit, Lorbrena and Braftovi. Its Internal Medicine products include Eliquis and the Premarin family. Its Inflammation & Immunology products include Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis and Cibinqo. It also offers Rimegepant and Zavegepant.

Read More

Analyst Price Target

Average54.30 (+22.96% Upside)
High75.00
Low44.00
Price44.16
No. of Analysts20
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
Daily
Weekly
Monthly
Moving AveragesNeutralBuyBuy
Technical IndicatorsSellStrong SellNeutral
SummaryNeutralNeutralNeutral
  • Project Veritas...
    0
    • Still aiming for sub 40
      1
      • Great long term er at this price
        1
        • please never effective.inbox me for fast rising stocks
          1
          • Adverse Effects Rife
            0
            • No logic for drop. This is a 60 Euro stock value
              0
              • It will drop like a stone, when the FDA release the data.
                0
            • time to jump ship. New variants are weaker, hospitalisations are down, no longer a need for vaccine or meds. vaccine centres in the UK are now practically empty. It was a good two year ride, but time to bail.
              4
              • Strong buyPresident Biden has doubled commitment of the Pfizer pill treatment to at least 20 million courses as the Covid omicron variant rages.
                0
                • Why TF is this not rising ?
                  0
                  • The Covid Detector device has been added to the Register of rapid tests for the detection of SARS-CoV-2 virus in Austria. This instant contactless detector from ML System
                    0